Cite

HARVARD Citation

    Bromberg, J. et al. (n.d.). OS2.5 Effect of rituximab in primary central nervous system lymphoma - results of the randomized phase III HOVON 105/ALLG NHL 24 study. Neuro-oncology. p. iii220. [Online]. 
  
Back to record